ELVN

Enliven Therapeutics, Inc. $44.63 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.3%
Next 1 week
-0.5%
Next 1 month
+1.5%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 64
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.01%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.00 +2.4% · Seasonal tilt (5y) -0.8%
$68M/day volume 79% volatility +86% 1-year -82% from ATH
52-week range · 63% of the way up · -28% from the high
$14.78$62.32

Earnings Full history →

Next report 2026-11-11 (Wednesday, after close, in 8 days) · EPS est. -0.45.

1-day std dev
3.6%
Finished up
64%
Biggest pop
+4.3%
Biggest drop
-10.4%

Standard deviation of the close-to-close move over the last 14 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-05 miss -0.38 -0.49 -29.8% -0.6% +1.0% -2.7%
2026-05-07 beat -0.41 -0.38 +7.3% +3.1% +1.1% +2.6%
2026-03-03 miss -0.47 -0.48 -1.1% -0.6% +4.3% +6.8%
2025-11-12 beat -0.46 -0.32 +31.2% +0.0% -0.1% +4.8%
2025-08-13 miss -0.42 -0.49 -16.7% -0.2% -1.1% -0.7%
2025-05-14 miss -0.50 -0.57 -13.0% -2.3% -10.4% -15.7%
2025-03-13 beat -0.52 -0.46 +11.1% +4.0% +2.2% +3.9%
2024-11-13 beat -0.50 -0.48 +4.4% +2.2% -3.4% -1.5%
2024-08-13 beat -0.56 -0.41 +27.1% +4.3% +1.3% +10.0%
2024-05-14 beat -0.57 -0.54 +4.7% +4.1% +0.5% -4.1%
2024-03-14 beat -0.54 -0.47 +13.0% -3.6% +3.7% +60.1%
2023-11-09 miss -0.47 -0.51 -7.9% +0.1% -1.5% -10.0%
2023-08-10 miss -0.40 -0.41 -3.4% -1.4% +0.1% -6.7%
2023-05-11 miss -0.52 -0.80 -53.9% -0.5% +1.6% +5.7%

Not investment advice.